The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, yesterday released a urging Congress to keep its commitment to lower drug prices. Seventeen organizations, including the AHA, this month urged Congress to resist any attempts from the pharmaceutical industry to undo during the lame duck session provisions included in the Bipartisan Budget Act to make prescription drugs more affordable for seniors. The legislation closes the Medicare Part D coverage gap or 鈥渄oughnut hole鈥 one year earlier and requires higher drug manufacturer discounts on brand name prescription drugs while enrollees are in the coverage gap.
 
 

Related News Articles

Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription鈥
Headline
The Department of Commerce yesterday released notices announcing national security investigations on imports of pharmaceuticals, pharmaceutical ingredients and鈥
News
The Centers for Medicare & Medicaid Services April 7 released finalized payment rates for calendar year 2026 Medicare Advantage and Part D plans. Payments鈥
Headline
The AHA today urged the Medicare Payment Advisory Commission to take specific actions on physician fee schedule payments following recommendations the鈥
Headline
The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug programs for contract year 2026. The鈥
Chairperson's File
Public
Rural hospitals and health systems face big challenges, but together 鈥 with a unified voice 鈥 we can work to ensure people living in rural communities get the鈥